Nicardipine treatment was found to be more therapeutically effective than NCT501, and this protective effect was eliminated in Aldh1a1-KO mice, suggesting the involvement of Aldh1a1 in the activity of nicardipine against renal fibrosis, but we could not rule out a potential off-target effect. Here, ALDH1A1 is linked to renal fibrosis.